Xylem Inc. Quarterly Cost of Revenue in USD from Q3 2010 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary: Xylem Inc. quarterly/annual Cost of Revenue history and growth rate from Q3 2010 to Q2 2024.
Xylem Inc. Cost of Revenue for the quarter ending June 30, 2024 was $1.35B, a 26.1% increase year-over-year.
Xylem Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $5.31B, a 41% increase year-over-year.
Xylem Inc. annual Cost of Revenue for 2023 was $4.65B, a 35.2% increase from 2022.
Xylem Inc. annual Cost of Revenue for 2022 was $3.44B, a 6.77% increase from 2021.
Xylem Inc. annual Cost of Revenue for 2021 was $3.22B, a 5.71% increase from 2020.

Cost of Revenue, Trailing 12 Months (USD)

Cost of Revenue, Quarterly (USD)

Cost of Revenue, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$5.31B	$1.35B	+$279M	+26.1%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-07-30
Q1 2024	$5.03B	$1.28B	+$379M	+42%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-02
Q4 2023	$4.65B	$1.36B	+$429M	+46%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-28
Q3 2023	$4.22B	$1.31B	+$456M	+53.3%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-10-31
Q2 2023	$3.76B	$1.07B	+$227M	+26.9%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-07-30
Q1 2023	$3.54B	$902M	+$97M	+12.1%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-02
Q4 2022	$3.44B	$933M	+$103M	+12.4%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-28
Q3 2022	$3.34B	$856M	+$63M	+7.95%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-10-31
Q2 2022	$3.27B	$844M	+$13M	+1.56%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-04
Q1 2022	$3.26B	$805M	+$39M	+5.09%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-04
Q4 2021	$3.22B	$830M	-$17M	-2.01%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-28
Q3 2021	$3.24B	$793M	+$34M	+4.48%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-01
Q2 2021	$3.2B	$831M	+$105M	+14.5%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-02
Q1 2021	$3.1B	$766M	+$52M	+7.28%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-04
Q4 2020	$3.05B	$847M	+$13M	+1.56%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-24
Q3 2020	$3.03B	$759M	-$28M	-3.56%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-02
Q2 2020	$3.06B	$726M	-$93M	-11.4%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-03
Q1 2020	$3.15B	$714M	-$49M	-6.42%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-04
Q4 2019	$3.2B	$834M	-$10M	-1.19%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-25
Q3 2019	$3.21B	$787M	+$5M	+0.64%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-10-29
Q2 2019	$3.21B	$819M	+$21M	+2.63%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-07-30
Q1 2019	$3.19B	$763M	+$6M	+0.79%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-05
Q4 2018	$3.18B	$844M	+$74M	+9.61%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-26
Q3 2018	$3.11B	$782M	+$58M	+8.01%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-10-31
Q2 2018	$3.05B	$798M	+$91M	+12.9%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-01
Q1 2018	$2.96B	$757M	+$98M	+14.9%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-02
Q4 2017	$2.86B	$770M	+$82M	+11.9%	Oct 1, 2017	Dec 31, 2017	10-K	2020-02-28
Q3 2017	$2.78B	$724M	+$184M	+34.1%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-10-30
Q2 2017	$2.59B	$707M	+$144M	+25.6%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-07-31
Q1 2017	$2.45B	$659M	+$141M	+27.2%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-01
Q4 2016	$2.31B	$688M	+$84M	+13.9%	Oct 1, 2016	Dec 31, 2016	10-K	2019-02-22
Q3 2016	$2.23B	$540M	-$11M	-2%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-10-31
Q2 2016	$2.24B	$563M	-$9M	-1.57%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-01
Q1 2016	$2.25B	$518M	-$4M	-0.77%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-02
Q4 2015	$2.25B	$604M	-$31M	-4.88%	Oct 1, 2015	Dec 31, 2015	10-K	2018-02-23
Q3 2015	$2.28B	$551M	-$36M	-6.13%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-01
Q2 2015	$2.32B	$572M	-$45M	-7.29%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-02
Q1 2015	$2.36B	$522M	-$42M	-7.45%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-03
Q4 2014	$2.4B	$635M	+$12M	+1.93%	Oct 1, 2014	Dec 31, 2014	10-K	2017-02-23
Q3 2014	$2.39B	$587M	+$6M	+1.03%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-10-29
Q2 2014	$2.39B	$617M	+$28M	+4.75%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-07-30
Q1 2014	$2.36B	$564M	+$19M	+3.49%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-04-30
Q4 2013	$2.34B	$623M	+$36M	+6.13%	Oct 1, 2013	Dec 31, 2013	10-K	2016-02-26
Q3 2013	$2.3B	$581M	+$24M	+4.31%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-10-28
Q2 2013	$2.28B	$589M	+$6M	+1.03%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-07-29
Q1 2013	$2.27B	$545M	-$17M	-3.03%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-04-29
Q4 2012	$2.29B	$587M	-$36M	-5.78%	Oct 1, 2012	Dec 31, 2012	10-K	2015-02-26
Q3 2012	$2.33B	$557M	-$17M	-2.96%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-10-29
Q2 2012	$2.34B	$583M	-$9M	-1.52%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-07-30
Q1 2012	$2.35B	$562M	+$9M	+1.63%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-04-30
Q4 2011	$2.34B	$623M			Oct 1, 2011	Dec 31, 2011	10-K	2014-02-27
Q3 2011		$574M	+$77M	+15.5%	Jul 1, 2011	Sep 30, 2011	10-Q/A	2012-11-06
Q2 2011		$592M			Apr 1, 2011	Jun 30, 2011	10-Q	2012-08-02
Q1 2011		$553M			Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-03
Q3 2010		$497M			Jul 1, 2010	Sep 30, 2010	10-Q	2011-11-21

* An asterisk sign (*) next to the value indicates that the value is likely invalid.